05.11.23 -- FDA's Project Orbis Gathers Momentum For Cell & Gene Therapies
05/11/23 Clinical Leader Newsletter
Stay updated with breaking news from Project Orbis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05/11/23 Clinical Leader Newsletter
Project Orbis has worked very well for oncology products. CBER Director Dr. Peter Marks has recently started promoting the development of a similar...
Lawmakers are stepping in to increase the number of rare disease and orphan drug experts who sit on advisory committees. As it stands now, advisory...
- Approval based on the DESTINY-Breast04 results which showed Enhertu reduced risk of disease progression or death by 50 per cent and increased overall survival
NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.